Low doses of oral fludarabine in previously untreated elderly patients affected by chronic lymphocytic leukemia: Experience of a single unit

被引：0
|
作者：
Quirino, A. A. [1 ]
Villa, M. R. [1 ]
Improta, S. [1 ]
Lucania, A. [1 ]
Sagristani, M. [1 ]
Correale, F. [1 ]
Mastrullo, L. [1 ]
机构：
[1] PO San Gennaro, ASL NA1, UOC Ematol, Naples, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：116 / 116
页数：1
相关论文
共 50 条
  • [21] Five-Year Experience With Single-Agent Ibrutinib in Patients With Previously Untreated and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (12) : 9 - 11
  • [22] Continuous High-Dose Chlorambucil in Previously Untreated Patients with Chronic Lymphocytic Leukemia-Single-Center Experience
    Basic-Kinda, Sandra
    Aurer, Igor
    Dujmovic, Dino
    Radman, Ivo
    Sertic, Dubravka
    Dubravcic, Klara
    Gjadrov-Kuvezdic, Koraljka
    Batinic, Drago
    Sucic, Mirna
    Labar, Boris
    BLOOD, 2009, 114 (22) : 936 - 937
  • [23] Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients
    Leporrier, M
    Chevret, S
    Cazin, B
    Boudjerra, N
    Feugier, P
    Desablens, B
    Rapp, MJ
    Jaubert, J
    Autrand, C
    Divine, M
    Dreyfus, B
    Maloum, K
    Travade, P
    Dighiero, G
    Binet, JL
    Chastang, C
    BLOOD, 2001, 98 (08) : 2319 - 2325
  • [24] Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia: a subgroup analysis of the GREEN study
    Bosch, Francesc
    Cantin, Guy
    Cortelezzi, Agostino
    Knauf, Wolfgang
    Tiab, Mourad
    Turgut, Mehmet
    Zaritskey, Andrey
    Merot, Jean-Louis
    Tausch, Eugen
    Trunzer, Kerstin
    Robson, Susan
    Gresko, Ekaterina
    Boettcher, Sebastian
    Foa, Robin
    Stilgenbauer, Stephan
    Leblond, Veronique
    LEUKEMIA, 2020, 34 (02) : 441 - 450
  • [25] Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia: a subgroup analysis of the GREEN study
    Francesc Bosch
    Guy Cantin
    Agostino Cortelezzi
    Wolfgang Knauf
    Mourad Tiab
    Mehmet Turgut
    Andrey Zaritskey
    Jean-Louis Merot
    Eugen Tausch
    Kerstin Trunzer
    Susan Robson
    Ekaterina Gresko
    Sebastian Böttcher
    Robin Foà
    Stephan Stilgenbauer
    Véronique Leblond
    Leukemia, 2020, 34 : 441 - 450
  • [26] Early results of modified fludarabine, cyclophosphamide, and rituximab (mFCR) for patients with previously untreated advanced chronic lymphocytic leukemia (CLL).
    Tarhini, A. A.
    Land, S.
    Lim, F.
    Kiefer, G. J.
    Pietragallo, L.
    Pinkerton, R. A.
    Sulecki, M.
    Meisner, D.
    Schaefer, P. M.
    Foon, K. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 360S - 360S
  • [27] Long-Term Survival After Fludarabine, Cyclophosphamide, and Rituximab Treatment in Previously Untreated Chronic Lymphocytic Leukemia Patients
    Mustafa, Shokhan Mohammad
    Yassin, Ahmed Khudair
    Hassan, Kawa M.
    Sadiq, Nawsherwan
    Nadihm, Marwa N.
    Abdulrahman, Lara Lateef
    Salahaden, Shlan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S263 - S264
  • [28] Long-term survival after fludarabine, cyclophosphamide, and rituximab treatment in previously untreated chronic lymphocytic leukemia patients
    Mustafa, Shokhan Mohammad
    Yassin, Ahmed Khudair
    Mohammed, Nawsherwan S.
    Shamoon, Rawand P.
    Karam, Marwa N.
    Mohammad, Shlan S.
    Abdulrahman, Lara Lateef
    Ahmed, Zhalla O.
    Rashid, Bryar Sabah
    Mahmood, Tavan, I
    Yousif, Rozhhat A.
    Hasan, Kawa M.
    Mohamed, Zeki A.
    Getta, Hisham A.
    Jalal, Sana D.
    Abdullah, Dana A.
    Abdulla, Basil K.
    Numan, Ghanim S.
    Karadagh, Ranan
    IRAQI JOURNAL OF HEMATOLOGY, 2021, 10 (02) : 139 - 145
  • [29] Long-Term Survival After Fludarabine, Cyclophosphamide, and Rituximab Treatment in Previously Untreated Chronic Lymphocytic Leukemia Patients
    Mustafa, Shokhan Mohammad
    Yassin, Ahmed Khudair
    Mohammed, Nawsherwan S.
    Shamoon, Rawand P.
    Karma, Marwa N.
    Mohammad, Shlan S.
    Abdulrahman, Lara Lateef
    Ahmed, Zhalla O.
    Rashid, Bryar Sabah
    Mahmood, Tavan I.
    Yousif, Rozhhat A.
    Hasan, Kawa M.
    Mohamed, Zaki A.
    Getta, Hisham A.
    Jalal, Sana D.
    Abdullah, Dana A.
    Abdulla, Basil K.
    Numan, Ghanim S.
    Karadagh, Ranan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S260 - S261
  • [30] Profile of obinutuzumab for the treatment of patients with previously untreated chronic lymphocytic leukemia
    Hill, Brian T.
    Kalaycio, Matt
    ONCOTARGETS AND THERAPY, 2015, 8 : 2391 - 2397
12345